The Food and Drug Administration approved a new treatment for severe frostbite that is intended to prevent the need to amputate fingers or toes. The Iloprost injection, marketed under the name Aurlumyn, is a vasodilator, which opens blood vessels and prevents clotting.
“This approval provides patients with the first-ever treatment option for severe frostbite,” said FDA’s Center for Drug Evaluation and Research Division of Cardiology and Nephrology Director Norman Stockbridge. “Having this new option provides physicians with a tool that will help prevent the life-changing amputation of one’s frostbitten fingers or toes.”
Iloprost was originally approved in 2004 for the treatment of pulmonary arterial hypertensio
As the Lord Leads, Pray with Us…
- For Commissioner Califf as he oversees the Food and Drug Administration.
- For FDA officials as they review and approve treatments and interventions for various illnesses and disorders.
- For the president and his advisors to receive God’s guidance as they address issues facing the nation.
